{
  "id": "5fda3dcaa43ad31278000006",
  "type": "list",
  "question": "Which cancer types are associated with mutations in the TWIST1 gene?",
  "ideal_answer": "Loss-of-function mutations of TWIST1, a catalytic component of polycomb repressive complex 1, are observed in ~\\n10% of all human cancers, including gastric, non-small cell lung, breast ductal carcinoma, nonsmall cell lung cancer, prostate cancer, ovarian cancer, breast tumor, papillary thyroid cancer, and gastric cancer.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/24117170",
    "http://www.ncbi.nlm.nih.gov/pubmed/21330172",
    "http://www.ncbi.nlm.nih.gov/pubmed/21876555",
    "http://www.ncbi.nlm.nih.gov/pubmed/30272327",
    "http://www.ncbi.nlm.nih.gov/pubmed/29123266",
    "http://www.ncbi.nlm.nih.gov/pubmed/29455655",
    "http://www.ncbi.nlm.nih.gov/pubmed/25368021",
    "http://www.ncbi.nlm.nih.gov/pubmed/25622896",
    "http://www.ncbi.nlm.nih.gov/pubmed/25892968",
    "http://www.ncbi.nlm.nih.gov/pubmed/28851812",
    "http://www.ncbi.nlm.nih.gov/pubmed/28466252",
    "http://www.ncbi.nlm.nih.gov/pubmed/23623921",
    "http://www.ncbi.nlm.nih.gov/pubmed/17437280",
    "http://www.ncbi.nlm.nih.gov/pubmed/21502402",
    "http://www.ncbi.nlm.nih.gov/pubmed/29477381",
    "http://www.ncbi.nlm.nih.gov/pubmed/19373776",
    "http://www.ncbi.nlm.nih.gov/pubmed/30265861",
    "http://www.ncbi.nlm.nih.gov/pubmed/29452232",
    "http://www.ncbi.nlm.nih.gov/pubmed/23364532",
    "http://www.ncbi.nlm.nih.gov/pubmed/20689556",
    "http://www.ncbi.nlm.nih.gov/pubmed/27524420",
    "http://www.ncbi.nlm.nih.gov/pubmed/19863427"
  ],
  "snippets": [
    {
      "text": "Here we have analysed a cohort of 26 women with BRCA1/2-negative hereditary breast cancer to study whether a proportion of these families might have mutations in Saethre-Chotzen-associated genes. DNA sequence analysis of TWIST1 showed no pathogenic mutations in the coding sequence in any of the 26 patients.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19863427",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Because of the potential importance of this finding, we organized a multicenter study enrolling people with TWIST1 mutation confirmed SCS to determine if an increased risk of cancer is present. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19373776",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "This Ser 68 is phosphorylated by p38, c-Jun N-terminal kinases (JNK), and extracellular signal-regulated kinases1/2 in vitro, and its phosphorylation levels positively correlate with Twist1 protein levels in human embryonic kidney 293 and breast cancer cells. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21502402",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "STAT3 mediates TGF-\u03b21-induced TWIST1 expression and prostate cancer invasion.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23623921",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "n the present study, we determined the underlying mechanisms of TGF-\u03b21-induced TWIST1 expression and its effect on prostate cancer cell invasion. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23623921",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "we demonstrate a mechanistic cascade of TGF-\u03b21 up-regulating STAT3 activation and HIF-1\u03b1 stabilization and subsequent TWIST1 expression, leading to prostate cancer invasion.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23623921",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Differential expression and activation of epidermal growth factor receptor 1 (EGFR1), ERK, AKT, STAT3, and TWIST1 in nonsmall cell lung cancer (NSCLC).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24117170",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Inhibition of TWIST1 leads to activation of oncogene-induced senescence in oncogene-driven non-small cell lung cancer.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23364532",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "silencing of TWIST1 in oncogene driver-dependent NSCLCs represents a novel and promising therapeutic strategy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23364532",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Silencing of TWIST1 in KRAS-mutant human NSCLC cell lines resulted in dramatic growth inhibition and either activation of a latent oncogene-induced senescence program or, in some cases, apoptosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23364532",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "the basic helix-loop-helix transcription factor Twist1 cooperates with mutant Kras to induce lung adenocarcinoma in transgenic mouse models and that inhibition of Twist1 in these models led to Kras-induced senescence.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23364532",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Structure-function studies of the bHLH phosphorylation domain of TWIST1 in prostate cancer cells",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25622896",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Lastly, the dual phosphatidylinositide 3-kinase (PI3K)-mammalian target of rapamycin (mTOR) inhibitor BEZ235 strongly attenuated TWIST1-induced migration that was dependent on the TQS motif. TWIST1 TQS phosphorylation state determines the intensity of TWIST1-induced pro-metastatic ability in prostate cancer cells, which may be partly explained mechanistically by TWIST1 dimeric partner choice.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25622896",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The hypo-phosphorylation mimic Twist1-AQA mutation displayed reduced pro-metastatic activity compared to wild-type TWIST1 in vitro, suggesting that phosphorylation of the TWIST1 TQS motif was necessary for pro-metastatic functions.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25622896",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Twist1 is a key regulator of cancer-associated fibroblasts",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25368021",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "In xenograft models, tumor infiltration of Twist1-expressing CAFs was enhanced strongly by ectopic IL6 expression in gastric or breast cancer cells.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25368021",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Enforced expression of Twist1 in normal fibroblasts was also sufficient to drive CAF marker expression and malignant character in gastric cancer cells both in vitro and in vivo.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25368021",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "TWIST1, an epithelial-mesenchymal transition (EMT) transcription factor, is critical for oncogene-driven non-small cell lung cancer (NSCLC) tumorigenesis. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28851812",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The Transcription Factor ETV5 Mediates BRAFV600E-Induced Proliferation and TWIST1 Expression in Papillary Thyroid Cancer Cells",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30265861",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "up-regulates Twist1 in non-small cell lung cancer cells leading to increased migration, invasion, and resistance to crizotinib",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29477381",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Combination of Twist1 siRNA and crizotinib significantly reduced cell vitality, inhibited cell invasion and migration, and promoted apoptosis in A549-CD74-ROS1 G2032R mutation cells",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29477381",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "hese results suggested that CD74-ROS1 G2032R mutation mediated EMT phenotype by increasing the expression of Twist1, resulting in drug resistance. Combination of Twist1 silence and ROS1 inhibitor may provide a potent strategy to treat the ROS1+ NSCLC patients with crizotinib resistance.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29477381",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29455655",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Our results implicate ETV6 as a potential marker for predicting efficacy of an EGFR-targeted anticancer approach. Combination treatment of TWIST1 inhibitors could sensitize the anti-proliferation effects of EGFR-TKIs.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29455655",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Long noncoding RNA PVT1 promotes EMT via mediating microRNA-186 targeting of Twist1 in prostate cancer",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29452232",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Furthermore, PVT1 can promote EMT by up-regulation of Twist1, a transcription factor associated with EMT. We then confirmed that PVT1 acts as a sponge for miRNA-186-5p and positively regulates Twist1 by a sponge effect.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29452232",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Mechanistically, Sox5 could bind to Twist1 promoter and active Twist1, which initiated EMT. Importantly, knockdown of Sox5 in prostate cancer cells resulted in less of the mesenchymal phenotype and cell migration ability.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29123266",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "we propose a new mechanism in which Smad3/Sox5/Twist1 promotes EMT and contributes to PCa progression.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29123266",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "TMPRSS4 Upregulates TWIST1 Expression through STAT3 Activation to Induce Prostate Cancer Cell Migration.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28466252",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Taken together, we demonstrated a mechanistic cascade of TMPRSS4 up-regulating STAT3 activation and subsequent TWIST1 expression, leading to prostate cancer migration",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28466252",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Phosphorylation of serine 68 of Twist1 by MAPKs stabilizes Twist1 protein and promotes breast cancer cell invasiveness.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21502402",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Twist1 is expressed in breast, liver, prostate, gastric and other types of cancers, and its expression is usually associated with invasive and metastatic cancer phenotypes.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21876555",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Germline mutation screening of the Saethre-Chotzen-associated genes TWIST1 and FGFR3 in families with BRCA1/2-negative breast cancer.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19863427",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Tethered TWIST1-E12 heterodimers phenocopied the Twist1-DQD mutation for many in vitro assays, suggesting that TWIST1 phosphorylation may result in heterodimerization in prostate cancer cells.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25622896",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Our results also indicate that the TWIST1 gene may be a novel breast cancer susceptibility gene.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17437280",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Structure-function studies of the bHLH phosphorylation domain of TWIST1 in prostate cancer cells.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25622896",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "In humans, a germline mutation (c.309C>G) in the TWIST1 oncogene may predispose to breast cancer and its expression has been associated with tumour progression and metastasis. I",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21330172",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Germline mutation screening of the Saethre-Chotzen-associated genes TWIST1 and FGFR3 in families with BRCA1/2-negative breast cancer",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19863427",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": " that the TWIST1 gene may be a novel breast cancer susceptibility gene. Additional studies are,",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17437280",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Foxa1 expression is linked with luminal breast cancer (LBC) with good prognosis, whereas Twist1 expression is associated with basal-like breast cancer (BLBC) with poor prognosis owing to its role in promoting epithelial-to-mesenchymal transition (EMT), invasiveness and metastasis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27524420",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Associations of gene\u2011wide SNPs in SNAI1 and TWIST1 with breast cancer and ovarian cancer susceptibility among Chinese Han women.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30272327",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "These results indicate that tamoxifen can significantly accelerate Twist1 degradation to suppress cancer cell invasion and metastasis, suggesting that tamoxifen can be used not only to treat ER-positive breast cancers but also to reduce Twist1-mediated invasion and metastasis in ER-negative breast cancers.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25892968",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In humans, a germline mutation (c.309C>G) in the TWIST1 oncogene may predispose to breast cancer and its expression has been associated with tumour progression and metastasis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21330172",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Twist1 levels were also elevated in metastatic prostate cancer-derived cell line DU145, in immortalized lung fibroblasts and in a subset of lung cancer samples, all in a mutant p53-dependent manner.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20689556",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "prostate cancer, breast cancer, lung cancer, thyroid cancer"
}